Valcyte

valganciclovir hydrochloride

For solution (oral) · NDA 022257

Last listed protection ends

December 11, 2027

The FDA lists 2 patents for Valcyte, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities